Gago Miguel F, Fernandes Vitor, Ferreira Jaime, Silva Hélder, Rodrigues Maria L, Rocha Luís, Bicho Estela, Sousa Nuno
Neurology Department, Centro Hospitalar do Alto Ave (CHAA), EPE, Guimarães, Portugal; Life and Health Sciences Research Institute (ICVS), School of Health Sciences, University of Minho, Braga, Portugal; ICVS-3Bs PT Government Associate Laboratory, Braga, Guimarães, Portugal.
Algoritmi Center, Department of Industrial Electronics, School of Engineering, University of Minho, Braga, Portugal.
Gait Posture. 2015 Feb;41(2):459-64. doi: 10.1016/j.gaitpost.2014.11.008. Epub 2014 Nov 24.
Postural stability analysis has shown that postural control is impaired in untreated idiopathic Parkinson's disease (IPD), even in the early stages of the disease. Vascular Parkinson's disease (VPD) lacks consensus clinical criteria or diagnostic tests. Moreover, the levodopa effect on postural balance remains undefined for IPD and even less so for VPD.
To characterize postural stability, using kinematic analysis with wearable inertial measurement units, in IPD and VPD patients without clinical PI, and to subsequently analyze the response to levodopa.
Ten patients with akinetic-rigid IPD and five patients with VPD were included. Clinical and postural stability kinematic analysis was performed before and after levodopa challenge, on different standing tasks: normal stance (NS), Romberg eyes open (REO) and Romberg eyes closed.
In the "off state", VPD patients had higher mean distances and higher maximal distance of p ostural sway on NS and REO tasks, respectively. VPD patients maintained a higher range of anterior-posterior (AP) postural sway after levodopa. In the absence of PI and non-significant differences in UPDRS-III, a higher mPIGD score in the VPD patients was mainly due to gait disturbance. Gait disturbance, and not UPDRS-III, influenced the degree of postural sway response to levodopa for VPD patients.
Quantitative postural sway evaluation is useful in the investigation of Parkinsonian syndromes. VPD patients have higher AP postural sway that is correlated with their gait disturbance burden and also not responsive to levodopa. These observations corroborate the interconnection of postural control and locomotor networks.
姿势稳定性分析表明,未经治疗的特发性帕金森病(IPD)患者即使在疾病早期,其姿势控制也会受损。血管性帕金森病(VPD)缺乏一致的临床标准或诊断测试。此外,左旋多巴对IPD患者姿势平衡的影响尚不明确,对VPD患者的影响更是知之甚少。
使用可穿戴惯性测量单元进行运动学分析,以表征无临床姿势不稳(PI)的IPD和VPD患者的姿势稳定性,并随后分析其对左旋多巴的反应。
纳入10例运动迟缓-僵硬型IPD患者和5例VPD患者。在左旋多巴激发前后,针对不同的站立任务进行临床和姿势稳定性运动学分析:正常站立(NS)、睁眼罗姆伯格试验(REO)和闭眼罗姆伯格试验。
在“关”状态下,VPD患者在NS和REO任务上分别具有更高的平均距离和更大的姿势摆动最大距离。左旋多巴治疗后,VPD患者的前后(AP)姿势摆动范围更大。在没有PI且统一帕金森病评定量表第三部分(UPDRS-III)无显著差异的情况下,VPD患者较高的平均帕金森病综合评分(mPIGD)主要归因于步态障碍。步态障碍而非UPDRS-III影响了VPD患者对左旋多巴的姿势摆动反应程度。
定量姿势摆动评估对帕金森综合征的研究有用。VPD患者具有更高的AP姿势摆动,这与他们的步态障碍负担相关,且对左旋多巴无反应。这些观察结果证实了姿势控制和运动网络之间的相互联系。